Policy implications of adjusting randomized trial data for economic evaluations: A demonstration from the ASCUS-LSIL triage study

Medical Decision Making

Volumn 32, Issue 3, 2012, Pages 400-427

  Campos, Nicole G ^a,b   Castle, Philip E ^c   Schiffman, Mark ^d   Kim, Jane J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c American Society for Clinical Pathology Institute   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

bias; cervical cancer; economic evaluation; human papillomavirus; randomized trial

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; COLPOSCOPY; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEM; ECONOMICS; EPIDEMIOLOGY; EVALUATION; FEMALE; HEALTH CARE POLICY; HUMAN; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STATISTICS; TIME; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH POLICY; HUMANS; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SELECTION BIAS; STATISTICS AS TOPIC; TIME; UNITED STATES; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84861805233     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X11428516     Document Type: Article

References (36)

1. Eccles M, Grimshaw J, Campbell M, Ramsay C. Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care. 2003 ; 12: 47-52
2. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000 ; 342: 1887-92
3. Rittenhouse BE. The relevance of searching for effects under a clinical-trial lamppost: a key issue. Med Decis Making. 1995 ; 14: 348-57
4. Rittenhouse BE. Exorcising protocol-induced spirits: making the clinical trial relevant for economics. Med Decis Making. 1997 ; 17: 331-9
5. Drummond M. Experimental versus observational data in the economic evaluation of pharmaceuticals. Med Decis Making. 1998 ; 18: 512-8
6. Eddy DM Modern Methods of Clinical Investigation. Gelijns AC, ed. Washington, DC: National Academy Press ; 1990 :
7. O'Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxaparin vs. warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Can Med Assoc J. 1994 ; 150: 1083-90
8. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007 ; 370: 890-907
9. ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet Gynecol. 2009 ; 114: 1409-20
10. National Cancer Institute. Fact sheet: Pap test. Available from: http://www.cancer.gov/cancertopics/factsheet/Detection/Pap-test
11. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002 ; 287: 2114-9
12. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011 ; 103: 368-83
13. Schiffman M, Kjaer SK. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003 ; 31: 14-9
14. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003 ; 127: 946-9
15. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study: design, methods and characteristics of trial participants. Acta Cytol. 2000 ; 44 (5). 726-42
16. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001 ; 93: 293-9
17. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003 ; 188: 1383-92
18. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002 ; 287: 2382-90
19. Kulasingam SL, Kim JJ, Lawrence WF, et al. Cost-effectiveness analysis based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2006 ; 98: 92-100
20. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol. 2008;112:1419-44.
21. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002 ; 94: 102-7
22. Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Molec Med. 2009 ; 13: 648-59
23. Brismar-Wendel S, Froberg M, Hjerpe A, Andersson S, Johansson B. Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. Br J Cancer. 2009 ; 101: 511-7
24. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000 ; 92: 397-402
25. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003 ; 188: 1393-400
26. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
27. Elliott AC Reisch JS. Implementing a multiple comparison test for proportions in a 2xc crosstabulation in SAS. Available from: http://www2.sas.com/proceedings/sugi31/204-31.pdf
28. Centers for Medicare and Medicaid Services. Clinical diagnostic laboratory fee schedule: April 2010. Available from: http://www.cms.gov/ ClinicalLabFeesched/02-clinlab.asp
29. Centers for Medicare and Medicaid Services. Physician fee relative value file: January 2010 (revised). Available from: http://www.cms.gov/ physicianfeesched/pfsrvf/ItemDetail.asp?ItemID=CMS1230197
30. Pretorius RG, Belinson JL, Zhang WH, Burchette RF, Elson P, Qiao YL. The colposcopic impression: is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?. J Reprod Med. 2001 ; 46: 724-8
31. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol. 2004 ; 191: 430-4
32. Jeronimo J, Massad S, Schiffman M. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. Am J Obstet Gynecol. 2007 ; 197: 8
33. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006 ; 108: 264-72
34. Buck C, Donner A. The design of controlled experiments in the evaluation of non-therapeutic interventions. J Chron Dis. 1982 ; 35: 531-8
35. Eddy DM. The confidence profile method: a Bayesian method for assessing health technologies. Oper Res. 1989 ; 37: 210-28
36. Eddy DM. Top 10 projects. Available from: http://www.davidmeddy.com/ Top10projects.htm#The%20Confidence%20Profile%20Method